These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 35593007

  • 1. Short-term effect of magnetic stimulation added to bladder training in women with idiopathic overactive bladder: A prospective randomized controlled trial.
    Tezer T, Yıldız N, Sarsan A, Alkan H.
    Neurourol Urodyn; 2022 Aug; 41(6):1380-1389. PubMed ID: 35593007
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of intravaginal electrical stimulation added to bladder training in women with idiopathic overactive bladder: A prospective randomized controlled trial.
    Yildiz N, Alkan H, Sarsan A.
    Int Braz J Urol; 2021 Aug; 47(6):1150-1159. PubMed ID: 34469668
    [Abstract] [Full Text] [Related]

  • 3. Which combination is most effective in women with idiopathic overactive bladder, including bladder training, biofeedback, and electrical stimulation? A prospective randomized controlled trial.
    Firinci S, Yildiz N, Alkan H, Aybek Z.
    Neurourol Urodyn; 2020 Nov; 39(8):2498-2508. PubMed ID: 32960999
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of intravaginal electrical stimulation with different treatment frequency in women with refractory idiopathic overactive bladder.
    Yildiz N, Alkan H, Findikoglu G.
    Int Braz J Urol; 2022 Nov; 48(4):662-671. PubMed ID: 35363455
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the efficacy of intravaginal electrical stimulation in women with idiopathic overactive bladder naive and refractory to pharmacological agents.
    Yildiz N, Unal B.
    Int Urogynecol J; 2023 Sep; 34(9):2099-2105. PubMed ID: 36976326
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bladder training compared to bladder training associated with pelvic floor muscle training for overactive bladder symptoms in women: A randomized clinical trial.
    Monteiro S, Rocha AK, Valim L, Silva SLAD, Riccetto C, Botelho S.
    Neurourol Urodyn; 2023 Nov; 42(8):1802-1811. PubMed ID: 37723948
    [Abstract] [Full Text] [Related]

  • 11. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
    Yüce T, Dökmeci F, Çetinkaya ŞE.
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
    [Abstract] [Full Text] [Related]

  • 12. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C, Sievert KD, MacDiarmid S, Khullar V, Radziszewski P, Nardo C, Thompson C, Zhou J, Haag-Molkenteller C.
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [Abstract] [Full Text] [Related]

  • 13. Isolated bladder training or in combination with other therapies to improve overactive bladder symptoms: a systematic review and meta-analysis of randomized controlled trials.
    Rocha AK, Monteiro S, Campos I, Volpato M, Verleun D, Valim L, Riccetto C, Botelho S.
    Braz J Phys Ther; 2024 Aug; 28(4):101102. PubMed ID: 39106788
    [Abstract] [Full Text] [Related]

  • 14. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C, Schneider T, Haab F, Sun F, Whelan L, Scholfield D, Dragon E, Mangan E.
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
    Herschorn S, Chapple CR, Abrams P, Arlandis S, Mitcheson D, Lee KS, Ridder A, Stoelzel M, Paireddy A, van Maanen R, Robinson D.
    BJU Int; 2017 Oct; 120(4):562-575. PubMed ID: 28418102
    [Abstract] [Full Text] [Related]

  • 16. Can botox improve night-time overactive bladder symptoms in women?
    Miotla P, Cartwright R, Futyma K, Bogusiewicz M, Skorupska K, Winkler I, Rechberger T.
    Neurourol Urodyn; 2017 Mar; 36(3):648-652. PubMed ID: 26915654
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of skin-adhesive low-level light therapy for overactive bladder: a Phase III study.
    Hwang WY, Kim YB, Lee SR, Suh DH, Kim K, No JH.
    Int Urogynecol J; 2022 Dec; 33(12):3573-3580. PubMed ID: 35389054
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of perineal electrical stimulation in men with urinary incontinence after radical prostatectomy. A prospective randomized controlled trial.
    Yıldız N, Çelen S, Özlülerden Y, Alkan H.
    Neurourol Urodyn; 2023 Jan; 42(1):340-348. PubMed ID: 36378836
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Flat Magnetic Stimulation for Urge Urinary Incontinence.
    Barba M, Cola A, Rezzan G, Costa C, Re I, Volontè S, Terzoni S, Frigerio M, Maruccia S.
    Medicina (Kaunas); 2023 Nov 14; 59(11):. PubMed ID: 38004048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.